LEF1 and chronic myelogenous leukemia, BCR-ABL1 positive: Western blot analysis of K562 cells treated with 2 μM imatinib demonstrated significantly downregulated LEF-1 protein levels (figure 1c), an outcome similar to that observed with patient sample CML-6 (figure 1b).